Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,499.58
(
0.74%
)
US TECH 100
28,814.80
(
0.79%
)
Dow Jones
50,065.58
(
0.75%
)
Brent Oil
102.87
(
-0.80%
)
Bitcoin
79,284.82
(
0.00%
)
News Focus
News Focus
Post# of 257560
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122977
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Bio_pete post# 86168

Tuesday, 05/04/2010 9:12:53 AM

Tuesday, May 04, 2010 9:12:53 AM

Post# of 257560
The FDA accepted Teva’s “low volume” Copaxone sNDA for review yesterday. (Source: today’s 1Q10 CC)


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today